Darlene Deptula-Hicks
Overview
Darlene Deptula-Hicks received an average of $998K in total compensation, including $495K in salary, at F-star Therapeutics from 2019 to 2021. Darlene Deptula-Hicks also received $710K at T2 Biosystems in 2017, an average of $693K at Pieris Pharmaceuticals between 2015 and 2016, and an average of $399K at ICAD from 2006 to 2011.
- 2021
- 2020
- 2019
- 2017
- 2016
- 2015
- 2011
- 2010
- 2009
- 2008
F-star TherapeuticsChief Financial Officer, Treasurer and Secretary
F-star TherapeuticsChief Financial Officer and Treasurer
F-star TherapeuticsChief Financial Officer and Treasurer
T2 Biosystemsformer Chief Financial Officer
Pieris PharmaceuticalsChief Financial Officer
Pieris PharmaceuticalsChief Financial Officer
ICADExecutive Vice President of Finance, Chief Financial Officer
ICADExecutive Vice President of Finance, Chief Financial Officer
ICADExecutive Vice President of Finance, Chief Financial Officer
ICADExecutive Vice President of Finance, Chief Financial Officer
Source: SEC filings on April 22, 2022, April 7, 2021, April 26, 2018, May 16, 2017, April 9, 2012, May 12, 2010, May 16, 2008, and June 13, 2007.
Related executives
We found 34 more executives who work or worked at F-star Therapeutics, T2 Biosystems, Pieris Pharmaceuticals, andICAD.
John Sperzel
T2 Biosystems
Chief Executive Officer
Stacey Stevens
ICAD
Chief Executive Officer
Michael Gibbs
T2 Biosystems
General Counsel
John Sprague
T2 Biosystems
Chief Financial Officer
Jonathan Go
ICAD
Chief Technology Officer
Charles Carter
ICAD
Chief Financial Officer
Michael Klein
ICAD
Chief Executive Officer
Dana Brown
ICAD